Oslo, Norway-headquartered NattoPharma has announced a new partnership with Brazilian supplements brand Nutriangels.
“Brazil is a burgeoning market wheres NattoPharma already enjoys an established presence. Nutriangels is one of the new pioneering supplement brands serving Brazil and we are thrilled to see this new customer expand our MenaQ7 offering with consumer-targeted, science-based products,” says Eric Anderson, senior vice president of global sales and marketing with NattoPharma.
Nutriangels launched K2 + featuring MenaQ7 in the second quarter of 2017, and it NattoPharma says it has already been well received. On the strength of of NattoPharma’s extensive clinical substantiation and patents, K2 + is positioned to support both bone and cardiovascular health.
“This milestone marks a welcome increase in awareness of the importance of Vitamin K2 for human health, and the global recognition that MenaQ7® is the clinically validated branded Vitamin K2 as MK-7 of choice,” adds Anderson.
NattoPharma ASA, based in Norway, is a leader in vitamin K2 research and development. The company is the exclusive international supplier of MenaQ7 Vitamin K2 as MK-7. It has a multi-year research and development programme aimed at substantiating and discovering the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements. With a global presence, the company established its North American subsidiary, NattoPharma USA, Inc., in Metuchen, NJ, and NattoPharma R&D Ltd. in Cyprus.